Standout Papers

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine 2018 2026 2020 2023 406
  1. ARISE: A Phase 3 randomized trial of erenumab for episodic migraine (2018)
    David W. Dodick, Messoud Ashina et al. Cephalalgia

Immediate Impact

1 from Science/Nature 50 standout
Sub-graph 1 of 17

Citing Papers

Targeting the gut microbiota-related metabolites for osteoporosis: The inextricable connection of gut-bone axis
2024 Standout
Pathology of pain and its implications for therapeutic interventions
2024 Standout
2 intermediate papers

Works of Kerry Palmer being referenced

The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study
2020
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
2018 Standout

Author Peers

Author Last Decade Papers Cites
Kerry Palmer 34 59 29 399 304 7 528
Bernice Kuca 66 45 27 185 134 10 510
Neeraj Dubey 15 21 39 207 330 8 601
B. Perrouin Verbe 15 143 13 153 130 9 478
Raymond Klein 33 64 49 71 110 10 605
PW Jones 50 55 89 112 171 8 615
A. J. Steck 22 35 81 166 265 10 612
Wil H.L. Hackeng 82 76 26 56 135 14 617
Gesche Neckelmann 11 150 27 83 169 16 631
F Ohanna 17 54 10 75 248 22 471
Meryem Saraçoğlu 4 37 6 188 135 17 519

All Works

Loading papers...

Rankless by CCL
2026